Filling the gap in CNS drug development: evaluation of the role of drug repurposing

Figures & data

Table 1. The number of source products and target indications included in the analysis.

Source products	118
Products repurposed once	80
Products repurposed twice	16
Products repurposed three times or more	22
Target indications	203
Products in development	101
Approved products	102
Reformulated products	16
Repositioned products	171
Reformulated and repositioned products	16

Figure 1. Drugs repurposed into CNS, by initial therapeutic area.

Figure 2. Drug repurposed into CNS, by target indication.

Figure 3. Initial therapeutic indication of drugs repurposed within CNS.